Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury.
@article{Dol1995EffectOS, title={Effect of SR 33805 on arterial smooth muscle cell proliferation and neointima formation following vascular injury.}, author={Fred́eŕique Dol and Paul Schaeffer and Isabelle Lamarche and A M Mar{\'e}s and Pierre Chatelain and Jean-M. Herbert}, journal={European journal of pharmacology}, year={1995}, volume={280 2}, pages={ 135-42 } }
19 Citations
The calcium inhibitor SR33805 reduces intimal formation following injury of the porcine carotid artery.
- Medicine, BiologyAtherosclerosis
- 2001
Effect of Azelnidipine on Angiotensin II-Mediated Growth-Promoting Signaling in Vascular Smooth Muscle Cells
- Biology, ChemistryMolecular Pharmacology
- 2005
Interestingly, azelnidipine increased rather than decreased the later ERK peaks in cells treated with small interfering RNA against mitogen-activated protein kinase phosphatase-1, which provides new insight into the manner in which calcium channels exert an essential action in the AT1 receptor-mediated growth-promoting actions in VSMCs.
Calcium channel antagonist verapamil inhibits neointimal formation and enhances apoptosis in a vascular graft model.
- Medicine, BiologyAmerican journal of surgery
- 2001
Calcium Channel Blocker Azelnidipine Enhances Vascular Protective Effects of AT1 Receptor Blocker Olmesartan
- Biology, MedicineHypertension
- 2004
It is suggested that azelnidipine could inhibit vascular injury at least partly independent of the inhibition of AT1 receptor activation and that azennidIPine could exaggerate the vascular protective effects of olmesartan, suggesting clinical possibility that the combination of CCB and ARB could be more effective in the treatment of vascular diseases.
Differential effects of Ca2+ channel blockers on Ca2+ transients and cell cycle progression in vascular smooth muscle cells.
- BiologyEuropean journal of pharmacology
- 1998
Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?
- BiologyInternational journal of cardiology
- 1997
Alteration of the [Ca2+]i‐force relationship during the vasorelaxation induced by a Ca2+ channel blocker SR33805 in the porcine coronary artery
- Biology
- 2000
SR33805 caused an apparent leftward shift of the [Ca2+]i‐force relationship of the contraction induced by cumulative application of extracellular Ca2+ during 118 mM K+‐depolarization.
Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?
- Biology, MedicineJournal of the American College of Cardiology
- 1999
Alteration of the [Ca(2+)](i)-force relationship during the vasorelaxation induced by a Ca(2+) channel blocker SR33805 in the porcine coronary artery.
- BiologyBritish journal of pharmacology
- 2000
SR33805 caused an apparent leftward shift of the [Ca(2+)](i)-force relationship of the contraction induced by cumulative application of extracellular Ca(2+) during 118 mM K(+)-depolarization.
Proteomic analysis and comparison of intra- and extracranial cerebral atherosclerosis responses to hyperlipidemia in rabbits
- Medicine, BiologyMolecular medicine reports
- 2017
Differential protein expression levels (TPM1, HSP70 and α-smooth muscle actin) between intra- and extracranial cerebral arteries may facilitate the identification of novel biological markers for the diagnosis and treatment of cerebral arteriosclerosis.
References
SHOWING 1-10 OF 39 REFERENCES
Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine.
- Biology, MedicineAtherosclerosis
- 1988
In vitro characterization of a novel Ca2+ entry blocker: SR 33805.
- Biology, MedicineEuropean journal of pharmacology
- 1993
Cellular processes in atherogenesis: potential targets of Ca2+ channel blockers.
- BiologyAtherosclerosis
- 1991
The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation.
- Biology, MedicineAtherosclerosis
- 1985
Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery.
- Medicine, BiologyAtherosclerosis
- 1987
Regulation of Ca2+ transport by platelet-derived growth factor-BB in rat vascular smooth muscle cells.
- BiologyCirculation research
- 1993
During prolonged stimulation by PDGF-BB, both Ca2+ influx and efflux are stimulated, resulting in a new intracellular Ca2+.
Long‐Term Effects of Verapamil on Aortic Smooth Muscle Cells Cultured in the Presence of Hypercholesterolemic Serum
- Biology, MedicineArteriosclerosis
- 1987
The presently reported results support the possibility that verapamil may impede the develipment of atheroma formaiton by reduction of smooth muscle cell proliferation in cholesterol-fed rabbits.
Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size.
- Biology, MedicineAtherosclerosis
- 1988
Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery.
- Biology, MedicineProceedings of the National Academy of Sciences of the United States of America
- 1989
It is concluded that platelets do not play a role in the initiation of smooth muscle cell proliferation after injury by balloon catheter but may regulate their movement into the intima.
Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells.
- Biology, MedicineThe Journal of clinical investigation
- 1991
It is concluded that VSMC FC content plays a role in regulating cellular calcium homeostasis, both under basal conditions and in response to selected agonists.